Profile
| Role | 10% Owner |
|---|---|
| Notability | 30/100 |
Board memberships
- Stagwell Inc
Updated Jul 16, 2026
Samaha Eli has filed 4 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $5.91M.
| Role | 10% Owner |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-08 | tbph | Theravance Biopharma, Inc. | S — Open-market sale | 5.6K | $17.17 | $96K |
| 2026-07-08 | tbph | Theravance Biopharma, Inc. | S — Open-market sale | 1.4K | $17.04 | $24K |
| 2026-07-02 | STGW | Stagwell Inc | A — Grant or award | 2.7K | $7.43 | $20K |
| 2026-07-01 | tbph | Theravance Biopharma, Inc. | S — Open-market sale | 37.8K | $17.00 | $643K |
| 2026-07-01 | tbph | Theravance Biopharma, Inc. | S — Open-market sale | 25.0K | $17.13 | $429K |
| 2026-07-01 | tbph | Theravance Biopharma, Inc. | S — Open-market sale | 273.9K | $17.23 | $4.72M |
| 2026-06-12 | STGW | Stagwell Inc | A — Grant or award | 23.0K | $0.00 | |
| 2026-04-02 | STGW | Stagwell Inc | A — Grant or award | 3.2K | $6.29 | $20K |
| 2025-10-01 | STGW | Stagwell Inc | A — Grant or award | 3.6K | $5.63 | $20K |
| 2025-07-01 | STGW | Stagwell Inc | A — Grant or award | 4.4K | $4.50 | $20K |
| 2024-10-03 | STGW | Stagwell Inc | A — Grant or award | 2.8K | $7.02 | $20K |
Samaha Eli is a corporate insider — currently tracked as 10% Owner of Theravance Biopharma, Inc. (tbph). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($5.91M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Samaha Eli profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.